Natixis’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-97,500
Closed -$656K 1431
2022
Q1
$656K Hold
97,500
﹤0.01% 938
2021
Q4
$882K Hold
97,500
﹤0.01% 942
2021
Q3
$986K Buy
+97,500
New +$1.07M ﹤0.01% 893
2018
Q3
Sell
-22,228
Closed -$266K 1008
2018
Q2
$266K Sell
22,228
-1,584
-7% -$21.2K ﹤0.01% 777
2018
Q1
$367K Sell
23,812
-181
-0.8% -$3.02K ﹤0.01% 710
2017
Q4
$392K Sell
23,993
-8,530
-26% -$165K ﹤0.01% 634
2017
Q3
$743K Buy
32,523
+8,786
+37% +$187K 0.01% 570
2017
Q2
$665K Sell
23,737
-1,569
-6% -$43.4K 0.01% 474
2017
Q1
$777K Buy
+25,306
New +$715K 0.01% 434

Other funds holding DBD

Natixis's DBD Position: Q2 2022 in Review

Natixis sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 97,500 shares — an estimated $656K sold.

Natixis first reported a position in DBD in Q1 2017 and held it in 9 quarters. The position peaked at $986K in Q3 2021. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Natixis reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Natixis sold 97,500 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $656K.
  • Natixis first reported a position in Diebold Nixdorf Incorporated in Q1 2017 and held it in 9 quarters.
  • Natixis's Diebold Nixdorf Incorporated position peaked at $986K in Q3 2021.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Natixis's 13F filing for Q2 2022, filed 12 Aug 2022.